Arterial/venous plasma nicotine concentrations following nicotine nasal spray

European Journal of Clinical Pharmacology

Volumn 55, Issue 9, 1999, Pages 639-643

  Guthrie, S K ^b,c   Zubieta, J K ^b,d   Ohl, L ^d   Ni, L ^a   Koeppe, R A ^c   Minoshima, S ^c   Domino, E F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cotinine; Nasal administration; Nicotine

Indexed keywords

COTININE; NICOTINE;

ADULT; ARTERIAL BLOOD; ARTICLE; CLINICAL ARTICLE; CLINICAL PHARMACOLOGY; DRUG RECEPTOR BINDING; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; INTRANASAL DRUG ADMINISTRATION; MALE; MUSCLE MASS; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; VENOUS BLOOD;

EID: 0032711368     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050686     Document Type: Article

References (16)

1. 1. Gourlay SG, Benowitz NL (1997) Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clin Pharmacol Ther 62: 453-463
2. 2. Henningfield JE, London ED, Benowitz NL (1990) Arterial-venous differences in plasma concentrations of nicotine after cigarette smoking. JAMA 253: 2050-2051
3. 3. Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, London ED (1993) Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend 33: 23-29
4. 4. Rose JE, Behm FM, Westman EC, Coleman RE (1999) Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: implications for addiction. Drug Alcohol Depend (in press)
5. 5. Snyder WS. Adopted by the International Commission on Radiological Protection (1992) Report of the Task Group on reference man. No. 23. Pergamon Press, New York, p 109
6. 6. Fagerström KO, Heatherton TF, Kozlowski LT (1991) Nicotine addiction and its assessment. Ear Nose Throat J 69: 763-768
7. 7. Domino EF, Zubieta J-K, Guthrie S, Ohl L, Ni L, Koeppe R, Cross D, Minoshima S (1999) Nicotine effects on regional cerebral blood flow in tobacco smokers (Abstr) Proceedings of Meeting of the Society for Neuroscience, Miami Beach, FL, October 23-28, Soc Neurosci [Abstr 25, Putl, p 285]
8. 8. Hariharan M, VanNoord T, Greden JF (1988) A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma. Clin Chem 34: 724-7299
9. 9. SAS (1996) Version 6.12. SAS Institute Inc, Cary, NC
10. 10. SCI Software (1992) PC NONLIN Version 4.0, Lexington, KY
11. 11. Warwick R, Williams PL (eds) (1973) Grays anatomy, 35th British edn. Saunders, Philadelphia, p 1177
12. 12. Chiou WL (1989) The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Clin Pharmacokinet 17: 175-199
13. 13. Gumbleton M, Øie S, Verotta D (1994) Pharmacokinetic-pharmacodynamic (PK-PD) modeling in non-steady-state studies and arterio-venous drug concentration differences. Br J Clin Pharmacol 38: 389-400
14. 14. Rowland M, Tozer TN (eds) (1995) Clinical pharmacokinetics, concepts and applications, 3rd edn. Williams and Wilkins, Philadelphia, p 138
15. 15. Benowitz NL, Jacob P (1994) Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 56: 483-493
16. 16. Perkins KA, Grobe JE, Stiller RL, Fonte C, Goettler JE (1992) Nasal spray nicotine replacement suppresses cigarette smoking desire and behavior. Clin Pharmacol Ther 52: 627-634